Growth hormone deficiency is a rare condition where the body doesn’t produce enough of the hormone needed for proper growth in children and healthy metabolism in adults. While the condition affects both young and old differently, modern medicine offers ways to replace the missing hormone and help patients live fuller lives.

How Medical Care Helps People with Growth Hormone Deficiency

When someone is diagnosed with growth hormone deficiency, the main goal of treatment is to restore what the body cannot produce on its own. For children, this means helping them reach a height closer to what would be expected for their age and allowing their bodies to develop normally. For adults, treatment focuses on improving energy levels, reducing unhealthy body fat, strengthening bones and muscles, and supporting overall well-being.^[1]

The approach to treating this condition depends heavily on the person’s age and the severity of their deficiency. A child who is barely growing will need different care than an adult experiencing fatigue and weight gain. Doctors also consider whether the deficiency was present from birth or developed later due to injury, surgery, or other health problems. The treatment plan is personalized, taking into account the individual’s specific needs and medical history.^[2]

There are standard treatments that have been used successfully for decades and are recommended by medical societies around the world. These involve replacing the missing growth hormone with a synthetic version that mimics what the body would naturally produce. At the same time, researchers continue to explore new therapies and refine existing approaches through clinical trials. These studies test innovative methods and help doctors understand how to use treatments more effectively and safely.^[1]

Standard Treatment Approaches

The cornerstone of treating growth hormone deficiency is growth hormone replacement therapy. This involves using a laboratory-made version of human growth hormone, also called somatotropin. The synthetic hormone is identical in structure to the natural hormone produced by the pituitary gland, which is a small gland at the base of the brain responsible for making several important hormones.^[13]

Growth hormone replacement is given through daily injections under the skin, usually in the evening to mimic the body’s natural pattern of releasing the hormone during sleep. Parents of young children are taught how to give these injections at home, and older children and adults can learn to do it themselves. The injection sites are rotated to prevent tissue damage, and modern injection devices have made the process much easier and less painful than in the past.^[5]

For children, the goal of treatment is to help them grow at a normal rate and reach an adult height that is within the expected range for their family. Doctors monitor growth closely by measuring height every few months and adjusting the dose of growth hormone based on the child’s response. Blood tests are also done regularly to check levels of a substance called insulin-like growth factor 1 (IGF-1), which is produced by the liver in response to growth hormone. IGF-1 levels help doctors know if the dose of growth hormone is appropriate.^[2]

Treatment typically continues until the child reaches their final adult height, which is determined by when the growth plates in their bones close. This usually happens during late adolescence. Some young people who had growth hormone deficiency as children may need to continue treatment into adulthood if testing shows they still have low growth hormone levels after they stop growing.^[10]

In adults, growth hormone replacement serves a different purpose. Since adults are no longer growing taller, the treatment focuses on improving body composition by increasing muscle mass and reducing excess body fat, especially around the waist. It also helps maintain bone strength, which is important for preventing fractures later in life. Many adults report feeling more energetic and experiencing better mood and quality of life with treatment.^[11]

The dose for adults is typically lower than for children and is adjusted based on how the person responds and whether they experience any side effects. Blood tests measuring IGF-1 levels help guide dose adjustments. The goal is to bring IGF-1 into the normal range without causing it to become too high, which could lead to unwanted effects.^[20]

Adults usually continue treatment indefinitely as long as it remains beneficial and well tolerated. Regular monitoring by a doctor is essential to ensure the treatment is working properly and to watch for any potential problems. This includes checking for changes in blood sugar levels, blood pressure, and cholesterol, as well as monitoring for any signs that other pituitary hormones might be affected.^[11]

The duration of treatment varies from person to person. In children, it may last several years until they reach their adult height. In adults with confirmed deficiency, treatment may be lifelong. Regular follow-up appointments allow doctors to assess whether the benefits continue to outweigh any risks and to make adjustments as needed.^[10]

Like any medical treatment, growth hormone replacement can cause side effects, although most people tolerate it well. In children, the most common side effects include pain or redness at the injection site, joint and muscle aches, and mild swelling in the hands and feet. These effects are usually temporary and often improve as the body adjusts to the treatment. Some children may develop a slight curvature of the spine or complain of headaches, which should be reported to their doctor.^[13]

In adults, side effects may include swelling in the arms and legs due to fluid retention, joint pain and stiffness, carpal tunnel syndrome (numbness and tingling in the hands), and muscle aches. These effects are often related to the dose being too high and can be managed by reducing the amount of growth hormone given. Starting with a lower dose and increasing gradually can help minimize these problems.^[20]

There has been concern about whether growth hormone treatment might increase the risk of certain health problems, particularly in relation to blood sugar control and the possibility of tumor growth. Long-term studies have shown that when used appropriately under medical supervision, growth hormone replacement does not significantly increase the risk of diabetes or cancer. However, people receiving treatment need regular monitoring to detect any potential issues early.^[20]

Innovative Therapies Being Tested in Clinical Trials

While daily injections of synthetic growth hormone remain the standard treatment, researchers are actively working on new approaches that could make treatment easier, more effective, or better suited to individual patients. Clinical trials are studies where new treatments are tested in people to see if they are safe and effective. These trials follow strict regulations and go through several phases before a new treatment can be approved for general use.^[10]

Phase I trials are the first stage of testing in humans. These small studies focus primarily on safety, looking at whether a new treatment causes any serious side effects and determining what dose might be appropriate. Phase I trials for growth hormone deficiency might test new ways of delivering growth hormone or new molecules that act similarly to natural growth hormone.^[26]

Phase II trials involve more people and focus on whether the new treatment actually works. Researchers measure specific outcomes, such as whether a child’s growth rate improves or whether an adult’s body composition changes. They also continue to monitor for side effects and refine the dosing. These trials help determine if a new approach is promising enough to move forward to larger studies.^[26]

One area of active research involves developing long-acting growth hormone formulations. These are modified versions of growth hormone that stay in the body longer, which means they could be given less frequently than daily injections. Some of these formulations might need to be injected only once a week or even less often. Several long-acting growth hormone products are being studied in clinical trials, with some showing promising results in both children and adults. If proven safe and effective, these could significantly reduce the burden of daily injections and improve quality of life for patients.^[10]

Another innovative approach being explored is the use of growth hormone secretagogues. These are substances that stimulate the pituitary gland to produce more of its own growth hormone rather than replacing it with synthetic hormone. In theory, this could lead to a more natural pattern of growth hormone release. Some secretagogues are being tested in clinical trials, although their effectiveness compared to standard growth hormone replacement is still being evaluated.^[10]

Researchers are also investigating whether other delivery methods might be possible. This includes exploring oral medications (pills or liquids) or patches that could deliver growth hormone through the skin. However, these approaches face significant challenges because growth hormone is a large protein molecule that is easily broken down in the digestive system and doesn’t easily pass through the skin. Despite these hurdles, scientists continue to work on new technologies that might one day make these delivery methods feasible.^[10]

Phase III trials are large studies that compare a new treatment directly with the current standard treatment. These trials involve hundreds or even thousands of patients and are designed to definitively show whether the new approach is as good as or better than existing treatments. They also provide detailed information about side effects and safety. For growth hormone deficiency, Phase III trials might compare a long-acting growth hormone formulation with daily injections to see if they produce similar improvements in growth or body composition.^[26]

Some clinical trials are testing whether certain genetic therapies might one day help people with growth hormone deficiency caused by specific genetic mutations. Gene therapy involves introducing genetic material into cells to correct a deficiency or provide a new function. While this approach is still highly experimental and far from routine clinical use, early research in animal models has shown some promise. If successful in humans, gene therapy could potentially offer a one-time treatment that would allow the body to produce its own growth hormone.^[10]

Phase IV trials take place after a treatment has been approved and is available for general use. These studies continue to monitor long-term safety and effectiveness and may discover rare side effects that weren’t apparent in earlier trials. They also help doctors understand how treatments work in real-world settings with diverse patient populations. Phase IV studies of growth hormone replacement continue to provide valuable information about optimal dosing, long-term outcomes, and quality of life.^[26]

Clinical trials for growth hormone deficiency are conducted in many countries around the world, including the United States, various European nations, and increasingly in other regions. Patients who are interested in participating in a clinical trial should discuss this option with their doctor. Not everyone is eligible for every trial, as studies have specific criteria about who can participate based on factors like age, severity of deficiency, previous treatments, and other health conditions.^[10]

Most common treatment methods

• Growth Hormone Replacement Therapy
  • Daily subcutaneous injections of synthetic human growth hormone (somatotropin) given in the evening to mimic natural hormone release patterns
  • Dose adjustments based on growth response in children and IGF-1 levels in both children and adults
  • Treatment continues until children reach adult height and may be lifelong in adults with confirmed deficiency
  • Monitoring includes regular measurements of height in children, blood tests for IGF-1 levels, and assessment of side effects
• Long-Acting Growth Hormone Formulations (Clinical Trials)
  • Modified growth hormone molecules designed to remain in the body longer, potentially requiring only weekly or less frequent injections
  • Currently being tested in Phase II and Phase III clinical trials in both pediatric and adult populations
  • Preliminary results suggest comparable effectiveness to daily injections with potentially improved convenience and quality of life
• Growth Hormone Secretagogues (Experimental)
  • Substances that stimulate the pituitary gland to produce more of its own growth hormone
  • Being evaluated in early-phase clinical trials as an alternative to direct hormone replacement
  • Effectiveness compared to standard treatment is still under investigation